Description: Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
Home Page: www.suzuken.co.jp
8 Higashi Kataha-machi
Nagoya,
461-8701
Japan
Phone:
81 52 961 2331
Officers
Name | Title |
---|---|
Mr. Shigeru Asano | Pres, CEO & Director |
Mr. Yoshiki Bessho | Supreme Advisor & Director |
Mr. Hisashi Tamura | Sr. Exec. Officer, Sr. GM of Corp. Management Headquarters & Director |
Ms. Chie Takahashi | GM of Pharmaceutical Affairs Supervisory Office, Exec. Officer & Director |
Exchange: PINK
Country: US
Currency: US Dollar ($)
Forward PE: | 0 |
---|---|
Trailing PE: | 17.9552 |
Price-to-Book MRQ: | 0.6732 |
Price-to-Sales TTM: | 0.001 |
IPO Date: | |
Fiscal Year End: | March |
Full Time Employees: | 14032 |